HAMLET information facilitated risk reassessment in six cases, most notably assignment to adverse risk through NUP98-NSD1 fusions in AML without class-defining lesions, or through EVI1 overexpression without inv(3)(q21q26). Here, NSD1 is linked to acute myeloid leukemia.